Navigation Links
Telik Announces Financial Results For 2008 Second Quarter
Date:8/11/2008

idates or any product that Telik may develop, or obtain marketing approval before Telik does, Telik's commercial opportunity will be reduced or eliminated, and if Telik does not obtain regulatory approval to market products in the U.S. and foreign countries, Telik will not be permitted to commercialize its product candidates. Detailed information regarding factors that may cause actual results to differ materially from the results expressed or implied by statements in this press release may be found in Telik's periodic filings with the Securities and Exchange Commission, including the factors described in the section entitled "Risk Factors" in its quarterly report on Form 10-Q for the quarter ended March 31, 2008. Telik does not undertake any obligation to update forward-looking statements contained in this press release.

TELIK, the Telik logo, TELINTRA, TELCYTA and TRAP are trademarks or registered trademarks of Telik, Inc.

Telik, Inc.

Statements of Operations

(In thousands, except per share amounts)

(Unaudited)

Three Months Ended Six Months Ended

June 30, June 30,

2008 2007 2008 2007

Operating costs and expenses:

Research and development $8,236 $11,869 16,431 $24,813

General and administrative 2,773 3,979 5,186 7,631

Restructuring costs - (33) - 1,356

Total operating costs and

expenses 11,009 15,815 21,617 33,800

Loss from operations (11,009) (15,815) (21,617) (33,800)

Interest and other income

(expense), net (2,560) 1,492 (1,760) 3,155

Net loss
'/>"/>

SOURCE Telik, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Telik Announces 2008 Second Quarter Financial Release, Conference Call and Webcast
2. Telik Announces Publication of Diabetes Research in Bioorganic & Medicinal Chemistry Letters
3. Telik Announces Presentation and Webcast at Needham Biotechnology Conference
4. Telik Announces First Quarter 2008 Financial Results
5. Telik Presents Preclinical Data at 99th Annual Meeting of the American Association for Cancer Research
6. Telik Announces Fourth Quarter and 2007 Year End Financial Results and 2008 Guidance
7. Telik Announces Revised Date for Year-End Financial Release, Conference Call and Webcast
8. Telik Announces Year-End Financial Release, Conference Call and Webcast
9. Telik Announces Presentation and Webcast at JPMorgan Healthcare Conference
10. Telik Announces Presentation and Webcast at UBS Global Life Sciences Conference
11. Telik Announces Presentation and Webcast at Bear Stearns Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... 2015 Shimadzu Scientific Instruments today ... UV-visible spectrophotometer. Offering wavelength scanning from 190 to ... for applications in a variety of industries, including ... user-friendly UV-1280 enables intuitive operation, while the enhanced ...
(Date:1/22/2015)... 21, 2015 Cambridge Semantics, the leading provider ... announced that 2014 was a record-breaking year across the board ... the Anzo Smart Data Platform and our Smart Data solutions, ... from diverse data which led to record growth for the ...
(Date:1/22/2015)... Diego, California (PRWEB) January 22, 2015 ... Promotional Offer to their comprehensive portfolio of Eppendorf ... allows customers to purchase a Centrifuge 5424/5424 R and ... Bundle of either Eppendorf Research plus or Eppendorf Reference ...
(Date:1/22/2015)... 2015 Selexis SA, a serial innovation ... Banks (RCBs) used for drug discovery to commercial manufacturing, ... include Next-Generation Sequencing (NGS) data packages. The ... manufacturing by ensuring the integrity of the gene, validation ...
Breaking Biology Technology:Shimadzu’s New Monitored Single-Beam UV-Vis Spectrophotometer Offers Comprehensive Measurement Options in a Compact Body 2Cambridge Semantics Announces Record Results for 2014 2Eppendorf Announces Promotional Bundle Which Includes: Eppendorf Centrifuge 5424, 3-Pack of Pipettes, and Tips - Available Now at Pipette.com 2Selexis Generated Research Cell Banks Now Fully Sequenced Using Next-Generation Sequencing 2
... BASKING RIDGE, N.J., Sept. 3 Regado Biosciences, ... with active control agents, announced today that David J. Mazzo, ... the 11th Annual Healthcare Conference of the Rodman & Renshaw ... on Thursday, September 10, 2009 (EDT). Dr. Mazzo,s ...
... /PRNewswire-Asia/ -- Sinovac Biotech Ltd. (NYSE: SVA ... today that,the State Food and Drug Administration (SFDA) has ... has issued Sinovac a,production license for this vaccine. , ... that PANFLU.1, Sinovac,s H1N1,vaccine, has a good safety and ...
... CARY, N.C., Sept. 3 Cornerstone Therapeutics Inc. ... focused on acquiring, developing and commercializing significant products primarily ... it has received the approval of the United States ... acquisition of the commercial rights to the antibiotic Factive(R) ...
Cached Biology Technology:Regado Biosciences to Present at the Rodman & Renshaw Global Investment Conference on September 10, 2009 2Sinovac Obtains Production License for H1N1 Vaccine 2Sinovac Obtains Production License for H1N1 Vaccine 3Cornerstone Therapeutics Receives Approval to Acquire Commercial Rights to the Antibiotic Factive(R) 2Cornerstone Therapeutics Receives Approval to Acquire Commercial Rights to the Antibiotic Factive(R) 3Cornerstone Therapeutics Receives Approval to Acquire Commercial Rights to the Antibiotic Factive(R) 4Cornerstone Therapeutics Receives Approval to Acquire Commercial Rights to the Antibiotic Factive(R) 5
(Date:12/22/2014)...  The 2014 Holiday Season may be the brightest ever ... that the long anticipated floodgates for consumer biometrics may ... smart phones, tablets, and wearable mobile devices that incorporate ... users with nearly 4.8 billion biometric devices by 2020.   ...
(Date:12/19/2014)... 2014 Research and Markets ( http://www.researchandmarkets.com/research/86ncd6/micro_market ) has ... America Perimeter Security Systems Market" report to their offering. ... North American perimeter security market is estimated to grow at ... U.S. market holds a larger share in this market, ...
(Date:12/19/2014)... LaunchKey , the first decentralized mobile authentication and authorization ... era, today announced the close of $3 million in ... Metamorphic Ventures with participation from ENIAC Ventures, Crosslink Capital, ... has raised $4 million to date, and will use ...
Breaking Biology News(10 mins):First Season of Holiday Shopping with Mobile Biometric Payments Wraps Up With a Present for Biometrics Industry: A Rosy Forecast for More Than 2 Billion Users of 4.8 Billion Mobile Biometric Devices by 2020 2Micro Market Monitor: North America Perimeter Security Systems Market (Intrusion Detection Sensor, Video Surveillance, Communication/Alarm and Notification, Access Control System) 2Micro Market Monitor: North America Perimeter Security Systems Market (Intrusion Detection Sensor, Video Surveillance, Communication/Alarm and Notification, Access Control System) 3LaunchKey Raises $3 Million in Additional Funding Led by Metamorphic Ventures 2LaunchKey Raises $3 Million in Additional Funding Led by Metamorphic Ventures 3
... major players in the cruise industry, including cruise ... with civil society organizations - are taking proactive ... tourism while preserving cruise destinations, according to a ... Stewardship in Cruise Destinations issued by Conservation International's ...
... There is growing concern about the threats that ... populations. , Consumers and environmentalists are concerned about ... in farmed strains at the genetic level are ... the journal Molecular Ecology, researchers have found scientific ...
... infectious disease researchers at The Miriam Hospital and Brown Medical ... HIV is also safe when applied as a vaginal microbicide ... HIV and other sexually transmitted diseases and may be formulated ... results of this study may change the way the research ...
Cached Biology News:Report finds cruise industry is protecting the precious places it visits 2Report finds cruise industry is protecting the precious places it visits 3Report finds cruise industry is protecting the precious places it visits 4Anti-HIV drug has potential to prevent transmission in women 2Anti-HIV drug has potential to prevent transmission in women 3
Ms anti-Cyclophilin D...
Protein Kinase D2 Immunogen: Human protein kinase D2. Storage: -20 C, Avoid Freeze/Thaw Cycles...
Request Info...
Immunogen: Recombinant rabbit tryptophan hydroxylase, isolated as inclusion bodies from E. coli and purified by preparative SDS-PAGE. Storage: -20 C, Avoid Freeze/Thaw Cycles...
Biology Products: